What About the Negative Predictive Value?
To the Editor:
The authors 1 should be congratulated for their work (April 2006) with this fascinating new technology. Electromagnetic navigation clearly appears to improve the sensitivity of bronchoscopy in the diagnosis of pulmonary nodules and masses. Nevertheless, the application of such technology must be put in context of its clinical use, in this case the evaluation of patients with lung masses suspicious for lung malignancy. The principal advantage of attempting a diagnostic procedure in an operable patient with a solitary lung lesion suspicious for lung cancer is to reliably confirm that a malignancy is not present. In other words, the negative predictive value of the test is its most important characteristic in this setting. This is the basis for the recommendation found in the American College of Chest Physicians (ACCP) lung cancer guidelines 2 stating that, with regard to transthoracic needle aspiration (TTNA), the false negative test result rate of TTNA is high (range, 0.20 to 0.30). Thus, TTNA is generally not useful in ruling out cancer. As such, TTNA has no role in patients who have lesions that are even moderately suspicious for lung cancer, and who appear to have early-stage disease and are candidates for surgical resection. Although a test that could reliably rule out lung cancer might be useful in this setting, the high FN [false negative] rate of TTNA makes reliance on a negative result untenable.
In essence, a patient with a positive biopsy result for malignancy will need surgical resection, and a patient with a negative finding will still need surgical resection given the poor negative predictive value of the test. In this patient population, TTNA has no impact on clinical management and can only lead to delays in definitive care and potential complications.
The negative predictive value of the described technique in this study, 1 although not commented on in the text, is in fact very similar to that described for TTNA. Of the five patients with negative biopsy results for cancer, four patients had falsenegative results. The negative predictive value is therefore one fifth (20%). The above ACCP recommendation on TTNA could therefore be extrapolated to this novel technique.
Until such time that a test can demonstrate a high enough negative predictive value to comfortably avoid surgical resection, the test may not lead to significant changes in management for operable patients with suspected resectable lung cancer. The utility of these tests will remain limited to confirmation of cancer in inoperable patients or those with nonresectable disease. 
Response
The discussion in the literature on the diagnostic management of patients with a peripheral lung lesion suspicious for malignancy is a never-ending saga. The findings on transthoracic fine-needle aspiration (TTNA) [or any other diagnostic procedure for lung cancer] are not always comparable because they are derived from highly varied patient populations. The predictive value of any test might change according to the prevalence of disease in any given population. If we are supposed to operate on every patient with a peripheral lung nodule, we will end up with an unacceptably high rate of surgery for benign lesions. This was clearly demonstrated by Swensen et al, 1 who recently showed a 90% rate of benign lesions when screening for lung cancer by CT. In our experience, the diagnostic yield of a combined fine-needle aspiration and core biopsy is 93.4% with a sensitivity of 91.5% and specificity of 100%. Core biopsy demonstrated specific benign disease in 87.8% of cases. 2 In the study published, 3 negative electromagnetic navigation bronchoscopy biopsy findings were followed by TTNA plus core biopsy, which detected malignancy in false-negative cases. Our position is that a comprehensive preoperative evaluation including positron emission tomography and TTNA as needed will avoid unnecessary surgery in cases of benign lesions and of neoplasms, such as lymphoma or small cell carcinoma, that are best treated by chemotherapy.
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Role for Transbronchial Biopsy in the Diagnosis of Usual Interstitial Pneumonia
We read with interest the article by Berbescu et al 1 regarding the role for transbronchial biopsy (TBB) in the diagnosis of usual interstitial pneumonia (UIP). The authors conclude that TBB may be more useful than previously appreciated in the diagnosis of UIP. We do not believe their data support this conclusion.
First, their analysis is purely retrospective and hence prone to multiple forms of bias. For example, as the authors themselves acknowledge, they were aware of the diagnosis prior to reviewing the TBB specimens. Without blinding of the pathologist as to the final diagnosis, one can draw no firm conclusions regarding the yield of TBB in patients suspected of having UIP. Second, selection bias is a major concern since subjects with UIP who underwent TBB are likely to be systematically different from those who did not undergo TBB. Third, the absence of a control arm of patients lacking UIP precludes any effort to calculate precisely the sensitivity and specificity of TBB. Similarly, they provide no denominator as to the number of subjects at either institution who underwent TBB for possible UIP during the study period.
Alternatively, two large, recent prospective analyses 2, 3 suggest that the value of TBB in suspected UIP is quite low. For example, Raghu and coworkers 2 evaluated 59 consecutive patients thought to have UIP and found TBB to be nondiagnostic in 85% of subjects. A multicenter investigation 3 reported an even lower yield for TBB (2 of 91 subjects). The low yield for TBB needs also to be balanced against the relative safety of surgical lung biopsy (SLB) in this population. One recent case series 4 documents that most patients suspected of having UIP tolerate this procedure well.
Concern about pathologic interpretation also merits consideration. Nine of the 21 subjects with UIP in the report by Berbescu et al 1 showed only features of nonspecific interstitial pneumonia on TBB. Hence, without proceeding to SLB, nearly 40% of the study population might have been substantially misclassified and perhaps faced a delayed referral for lung transplantation. Furthermore, in the hands of nonpulmonary pathologists there is the potential for substantial misdiagnosis. Even with large tissue specimens, nonpulmonary pathologists misdiagnosis UIP frequently. 5 Increased reliance on TBB might further compound this issue. In short, although intriguing that in hindsight evidence of UIP can be detected on TBB, the data presented by Berbescu and colleagues 1 should not prompt clinicians to routinely rely on TBB as a diagnostic test either to exclude or to confirm the diagnosis of UIP. 
Response
I believe that Drs. Shorr, Lettieri, and Helman misinterpreted the message of our article (May 2006). 1 This work generated a hypothesis that will require further testing. It was not intended to produce a clinical recommendation to use transbronchial lung biopsies (TBBs) to diagnose usual interstitial pneumonia (UIP). In our article, we clearly state that TBBs should be tested in a blinded fashion and in a cohort of diffuse lung diseases including UIP and non-UIP cases. 1 However, it is undeniable, as we show in several of our figures, that features specific for UIP, such as patchwork pattern of interstitial fibrosis, fibroblastic foci, and honeycomb change, 2,3 are readily recognizable in many TBB specimens. 1 We did not report findings of nonspecific interstitial pneumonia in 9 of 21 patients, as Drs. Shorr, Lettieri, and Helman state. We make clear in the "Materials and Methods" section that findings were "nonspecific" if there was only interstitial fibrosis on TBB specimens. 1 Unfortunately, it has become accepted, despite lack of convincing data, that TBBs are not useful in diagnosing idiopathic interstitial pneumonias. However, if in the future TBBs are found useful in diagnosing UIP from a pool of patients with diverse idiopathic interstitial pneumonias, many unnecessary surgical lung biopsies with associated morbidity and mortality could be prevented. 4 
David

Allergic Rhinitis May Be Important in Snoring Infants
We read with interest the article by Kalra et al, 1 who found that the prevalence of habitual snoring for 1-year-old children was 15% in a high-risk group for atopy, ie, children born to atopic parents. This prevalence was significantly higher than that reported in older children, 10.9% in 6-to 12-year-old children in Hong Kong, 2 and 10 to 14% in Ͻ 6-year-olds in Europe and the United States. 3 This higher prevalence is most likely due to the fact that 29% of this group of infants were atopic, and it is not surprising that Kalra et al 1 found that the presence of atopy increased the risk of habitual snoring (odds ratio, 2.0; 95% confidence interval, 1.2 to 3.0), a common symptom of obstructive sleep apnea syndrome (OSAS). 4 This was similar to previous findings in Hong Kong, 2 when we found allergic rhinitis to be a significant risk factor for witnessed apnea with an adjusted odds ratio of 2.19, another symptom of OSAS as well as in the United States. 5 It is unfortunate that Kalra et al 1 did not report the prevalence of nasal symptoms in their cohort, as the data would have shed light on the mechanisms that link habitual snoring and atopic status, possibly allergic rhinitis. Other important data that were not reported were the parts played by individual allergens, especially the airborne allergens vs food allergen. These data would help determine whether the inhaled route or the ingested route is important in the habitual snoring infants. In the study of Kalra et al, 1 the definition of positive atopic status for egg white and whole milk was wheal Ն 3 cm than the negative control, and this would be associated with a high false-positive rate. 6 Allergic rhinitis leads to markedly increased nasal resistance, and Rappai et al 7 found that nasal congestion was a strong independent risk factor for snoring and an increased likelihood for moderate or severe sleep-disordered breathing. In conclusion, Kalra et al 1 reported an important study about infantile snoring, but important data were not included that may shed more light on this underrecognized symptom. Nevertheless, all medical practitioners dealing with atopic infants should ask the same question as did Kalra et 
